絞り込み

17092

広告

「"Glorieux FH "[Author]」の検索結果

282件中 101件~120件表示    検索結果をPubMedで見る PubMedで見る

Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.

Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.

Intracortical remodeling during human bone development--a histomorphometric study.

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.

Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.

Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.

Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.

Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy.

Bone resorption in infants of diabetic mothers.

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta.

Schmid type of metaphyseal chondrodysplasia and COL10A1 mutations--findings in 10 patients.

Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?

Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome.

Caffey disease: an unlikely collagenopathy.

  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8
  8. 9
Sort by
※並べ替えは表示に時間がかかります